|
Volumn 31, Issue 11, 2013, Pages 945-947
|
Drugs with breakthrough status charm investors.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEW DRUG;
BIOTECHNOLOGY;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
DRUG INDUSTRY;
ECONOMICS;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LEGAL ASPECT;
NOTE;
UNITED STATES;
BIOTECHNOLOGY;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUGS, INVESTIGATIONAL;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84900864396
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1113-945 Document Type: Note |
Times cited : (6)
|
References (0)
|